13F Filings/Crestline Management, L.P.

Crestline Management, L.P.

Hedge FundCIK0001536054LocationFORT WORTH, TX 76102, United States

Long U.S. equity positions disclosed to the SEC on Form 13F-HR.

Latest filingQ1 2026Quarter ended31 Mar 2026Filed15 May 2026
Portfolio Turnover
14%
Of book traded, QoQ
Positions
3
Long U.S. equities
Top 10 Concentration
100%
Of reported value
QoQ Change
$-7.1M
Value change
Assets under management
Form ADV RAUM · client mix · 13F over time
13F AUM over time
$46M
Q1 ’26 · 13F AUM
13%
2 quarters
Showing the last 5 years of filings. Want this fund’s full history back to inception?
Reported Holdings
Q1 2026 · upgrade to Pro for past quarters
★ Position spotlightDNLIDENALI THERAPEUTICS INC · 91.7% of book
🔒
See how this position changed across every quarter
Multi-quarter 13F position history — shares held, buys & sells, and price over time — is a Pro feature. The latest snapshot below stays free.
SecuritySharesMarket ValueEst. CostLast PxEst. Return% PortfolioΔ SharesAction
DENALI THERAPEUTICS INC
DNLI· Health Care
2.21MSH$42.4M~$19.20$23.1120.4%91.7% 21.3%Reduced
SANA BIOTECHNOLOGY INC
SANA· Health Care
756KSH$2.2M~$2.88$3.1810.4%4.7% 38.1%Reduced
8X8 INC NEW
EGHT· Information Technology
991KSH$1.6M~$1.66$1.744.8%3.6% 0.0%Added
DNLIDENALI THERAPEUTICS INCReduced
$42.4M· 91.7%· 2.21M SH· 21.3%· cost $19.20· last $23.11· 20.4%
Health Care · COM · DFND
SANASANA BIOTECHNOLOGY INCReduced
$2.2M· 4.7%· 756K SH· 38.1%· cost $2.88· last $3.18· 10.4%
Health Care · COM · DFND
EGHT8X8 INC NEWAdded
$1.6M· 3.6%· 991K SH· 0.0%· cost $1.66· last $1.74· 4.8%
Information Technology · COM · DFND
Sector Breakdown
Q1 2026
Health Care96.4% · $44.6M
Information Technology3.6% · $1.6M